What is MayLips?
Operating as a specialized online marketplace, MayLips serves as a critical node in the supply chain for medical aesthetics, focusing primarily on dermal fillers, botulinum toxins, and advanced skincare solutions. Since its inception in 2014, the company has carved out a distinct market position by bridging the gap between high-end manufacturers and medical professionals. By prioritizing competitive wholesale pricing and logistical efficiency, MayLips has established itself as a reliable partner for clinics and practitioners seeking to optimize their procurement processes while ensuring the integrity of their medical inventory.
How much funding has MayLips raised?
MayLips has raised a total of $131K across 1 funding round:
Debt
$131K
Debt (2021): $131K with participation from PPP
Key Investors in MayLips
PPP
Public-Private Partnership
What's next for MayLips?
With this latest round of financing, MayLips is well-positioned to accelerate its expansion into new geographic markets and enhance its digital procurement platform. The company is expected to leverage this capital to strengthen its supply chain resilience and broaden its portfolio of medical devices. As the demand for non-surgical aesthetic procedures continues to rise globally, MayLips is strategically prepared to capture additional market share by scaling its customer service operations and investing in technological infrastructure that supports seamless, secure, and rapid delivery of sensitive medical supplies to its professional clientele.
See full MayLips company page
